Contemporary Management of Hemophilia A: Expert Guidance to Improve Patient Outcomes

In this comprehensive program centered around live CCO Webinars at ASH 2020, experts discuss key developments in management of hemophilia A. Review their insights by reading focused clinical commentaries along with watching the on-demand Webcast and downloading slides from the symposium.
Miguel A. Escobar, MD
Program Director
Michael Callaghan, MD
Stacy Croteau Headshot
Stacy E. Croteau, MD, MMS
Miguel A. Escobar, MD
person default
Rebecca Kruse-Jarres, MD, MPH
Guy A. Young, MD

ClinicalThought

Building from a solid foundation based on direct factor VIII replacement, management of hemophilia A now includes nonfactor therapies. Here’s my take on progress and future directions.

Guy A. Young, MD Released: October 14, 2020

Get an expert’s thoughts on key data most likely to affect care of patients with hemophilia presented at ASH 2020.

Stacy Croteau Headshot Stacy E. Croteau, MD, MMS Released: December 18, 2020

Read a discussion with 3 experts answering audience questions following 2 live Webcasts on contemporary management of hemophilia A.

Michael Callaghan, MD Miguel A. Escobar, MD person default Rebecca Kruse-Jarres, MD, MPH Released: February 16, 2021

Downloadable Slidesets

Download this slideset to learn more about up-to-date management strategies to optimize outcomes for patients with hemophilia A.

Michael Callaghan, MD Released: December 3, 2020

Learn more about strategies to mitigate complications associated with factor replacement therapy and overcoming barriers to effective therapy

person default Rebecca Kruse-Jarres, MD, MPH Released: December 4, 2020

Learn about the latest data on nonfactor replacement therapies and their evolving role in the management of hemophilia A in by downloading this slideset.

Miguel A. Escobar, MD Released: December 4, 2020

Download this summary slideset of key takeaways from a CCO Live Webinar for expert insight on contemporary best practice management of hemophilia A, including prophylaxis, improving adherence, and emerging strategies to improve patient outcomes.

Michael Callaghan, MD Miguel A. Escobar, MD person default Rebecca Kruse-Jarres, MD, MPH Released: December 10, 2020

On-Demand Webcast

Learn about contemporary management of hemophilia A from a panel of experts in this on-demand Webcast from a live Webinar.

Miguel A. Escobar, MD
Program Director
Michael Callaghan, MD person default Rebecca Kruse-Jarres, MD, MPH
Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: December 10, 2020 Expired: December 9, 2021

With updates from ASH 2020, current management of hemophilia A is discussed by a panel of experts in this on-demand Webcast from a live Webinar.

Miguel A. Escobar, MD
Program Director
Michael Callaghan, MD person default Rebecca Kruse-Jarres, MD, MPH
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: February 25, 2021 Expired: February 24, 2022

Podcasts

In this podcast episode, listen to Michael Callaghan, MD; Miguel A. Escobar, MD; and Rebecca Kruse-Jarres, MD, MPH, as they answer questions from a clinician audience on new and established approaches for managing hemophilia A in pediatric and adult patients.

Michael Callaghan, MD Miguel A. Escobar, MD person default Rebecca Kruse-Jarres, MD, MPH Released: February 4, 2021
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Genentech, a member of the Roche Group
Sanofi Genzyme Corporation
Takeda Pharmaceutical Company Ltd

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue